Oxford Nanopore Technologies (OTCMKTS:ONTTF) Trading Up 1.2% – Still a Buy?

Oxford Nanopore Technologies plc (OTCMKTS:ONTTF) shares rose 1.2% on Tuesday . The stock traded as high as $1.76 and last traded at $1.75. 15,758 shares were traded during mid-day trading, a decline of 23% from the average session volume of 20,592 shares. The stock had previously closed at $1.73.

Wall Street Analysts Forecast Growth

Separately, Citigroup reaffirmed a “buy” rating on shares of Oxford Nanopore Technologies in a research note on Friday, July 10th. Two equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Oxford Nanopore Technologies presently has an average rating of “Buy”.

Oxford Nanopore Technologies Stock Down 4.4%

The firm has a 50 day moving average price of $1.60 and a 200-day moving average price of $1.70.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells.